logo

Grifols (GRFS)



Trade GRFS now with
  Date
  Headline
10/9/2020 6:26:17 AM Grifols Says Anti-SARS-CoV-2 Hyperimmune Globulin Begins Clinical Trial To Test Safety
9/7/2020 2:53:03 AM Grifols To Acquire Remaining Stock Of Alkahest For $146 Mln On A Debt-free Basis
7/28/2020 10:45:15 AM Grifols Says Delivers First Manufactured Batches Of Its Anti-SARS-CoV-2 Hyperimmune Globulin For Clinical Trials
7/20/2020 2:45:41 AM Grifols Executes Purchase Arrangements With South Korean-based GC Pharma
7/9/2020 8:20:52 AM Rigel Pharma Announces Availability Of TAVLESSE In Europe
6/11/2020 4:05:20 AM Grifols Announces Start Of Production Of Its Anti-SARS-CoV-2 Hyperimmune Immunoglobulin With Specific Antibodies
5/26/2020 9:01:41 AM Medical Researchers, Life Science Companies, COVID-19 Survivors Launch National Campaign To Drive Blood Plasma Donation
5/7/2020 9:32:25 AM Grifols Receives FDA Approval For Procleix Panther System Featuring ART For Use With Certain U.S. Licensed Products
2/27/2020 3:40:38 AM Grifols FY Revenue EUR 5.099 Bln, Up 13.6%
7/4/2019 11:52:58 AM Grifols Announces FDA Approval Of Xembify For Primary Immunodeficiencies
7/3/2019 5:06:13 AM Grifols Selected By Soludia Maghreb As Main Supplier For New Manufacturing Plant In Northern Africa
1/23/2019 7:31:28 AM Rigel Pharma Signs Collaboration, License Deal With Grifols, S.A. To Commercialize Fostamatinib In Europe
1/8/2019 7:39:03 AM Grifols Receives FDA Approval Of Erytra Eflexis
10/12/2018 9:51:54 AM FDA Oks Grifols ID CORE XT Test For Molecular Red Blood Cell Typing